Emmaus Life Sciences is a biopharmaceutical company that provides treatments and therapies for rare and orphan diseases. It focuses on such genetic disorders as sickle cell disease. The company develops an oral pharmaceutical grade L-glutamine treatment for sickle cell anemia and sickle ß0-thalassemia.